Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Neuropathology, Neuroimaging, and Fluid Biomarkers in Alzheimer's Disease 2024-03-27
  2. MRI and fluid biomarkers reveal determinants of myelin and axonal loss with aging 2023-02-10
  3. N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases 2022-08-01

Studies

6 studies carry this tag.

Date range

2020 to 2024

Top journals

  • Annals of clinical and translational neurology 1
  • Brain : a journal of neurology 1
  • Continuum (Minneapolis, Minn.) 1
  • Diagnostics (Basel, Switzerland) 1
  • Journal of neurology, neurosurgery, and psychiatry 1

6 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Neuropathology, Neuroimaging, and Fluid Biomarkers in Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Diagnostics (Basel, Switzerland) 2024-03-27 Biomarkers

    An improved understanding of the pathobiology of Alzheimer's disease (AD) should lead ultimately to an earlier and more accurate diagnosis of AD, providing the opportunity to intervene earlier in the disease process and to improve outcomes.

  2. MRI and fluid biomarkers reveal determinants of myelin and axonal loss with aging

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Annals of clinical and translational neurology 2023-02-10 Biomarkers

    Plasma biomarkers of neuronal injury and astrogliosis are associated with reduced axonal density and region-specific myelin content.

  3. N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases

    ✓ Peer-reviewed alzhub usefulness score 59 out of 100. Brain : a journal of neurology 2022-08-01 Biomarkers

    After analytical validation, the diagnostic performance of these biomarkers was evaluated in CSF and compared with the Innotest total tau (and as proof of concept, with N-p-tau181 and N-p-tau217) in three clinical cohorts (n = 342 total).

  4. Fluid Biomarkers in Dementia Diagnosis

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Continuum (Minneapolis, Minn.) 2022-06-01 Biomarkers

    CSF and blood-based biomarkers can evaluate for a range of neurologic disorders that are associated with dementia, including AD.

  5. Fluid biomarkers in frontotemporal dementia: past, present and future

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Journal of neurology, neurosurgery, and psychiatry 2020-11-13 Biomarkers

    The frontotemporal dementia (FTD) spectrum of neurodegenerative disorders includes a heterogeneous group of conditions.

  6. Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic review

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Journal of the neurological sciences 2020-05-11 Biomarkers

    Several promising novel biomarkers were highlighted in this review.

All topic tags with their study counts